PortfoliosLab logoPortfoliosLab logo
SE vs. ZVRA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

SE vs. ZVRA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sea Limited (SE) and Zevra Therapeutics Inc. (ZVRA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SE achieves a -34.98% return, which is significantly lower than ZVRA's 41.18% return.


SE

1D
-3.21%
1M
-11.31%
YTD
-34.98%
6M
-33.66%
1Y
-46.36%
3Y*
8.08%
5Y*
-21.47%
10Y*

ZVRA

1D
-2.47%
1M
13.76%
YTD
41.18%
6M
51.86%
1Y
35.01%
3Y*
29.54%
5Y*
-2.85%
10Y*
-16.40%
*Multi-year figures are annualized to reflect compound growth (CAGR)

SE vs. ZVRA - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
SE
Sea Limited
-34.98%20.24%161.98%-22.16%-76.74%12.39%394.90%255.30%-15.08%-17.97%
ZVRA
Zevra Therapeutics Inc.
41.18%7.43%27.33%42.70%-47.30%-22.23%84.70%-78.71%-56.05%10.96%

Correlation

The correlation between SE and ZVRA is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.13

Correlation (3Y)
Calculated over the trailing 3-year period

0.17

Correlation (5Y)
Calculated over the trailing 5-year period

0.26

Correlation (All Time)
Calculated using the full available price history since Oct 20, 2017

0.20

The correlation between SE and ZVRA shifts across timeframes, from 0.13 (1 year) to 0.26 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

SE:

$52.76B

ZVRA:

$761.92M

EPS

SE:

$2.57

ZVRA:

$2.16

PE Ratio

SE:

32.21

ZVRA:

5.85

PS Ratio

SE:

2.06

ZVRA:

5.94

PB Ratio

SE:

4.11

ZVRA:

3.70

Total Revenue (TTM)

SE:

$25.19B

ZVRA:

$122.29M

Gross Profit (TTM)

SE:

$11.15B

ZVRA:

$104.94M

EBITDA (TTM)

SE:

$2.33B

ZVRA:

$149.15M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SE vs. ZVRA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SE
SE Risk / Return Rank: 1010
Overall Rank
SE Sharpe Ratio Rank: 77
Sharpe Ratio Rank
SE Sortino Ratio Rank: 88
Sortino Ratio Rank
SE Omega Ratio Rank: 88
Omega Ratio Rank
SE Calmar Ratio Rank: 1313
Calmar Ratio Rank
SE Martin Ratio Rank: 1313
Martin Ratio Rank

ZVRA
ZVRA Risk / Return Rank: 6060
Overall Rank
ZVRA Sharpe Ratio Rank: 6161
Sharpe Ratio Rank
ZVRA Sortino Ratio Rank: 6262
Sortino Ratio Rank
ZVRA Omega Ratio Rank: 6161
Omega Ratio Rank
ZVRA Calmar Ratio Rank: 6060
Calmar Ratio Rank
ZVRA Martin Ratio Rank: 5757
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SE vs. ZVRA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Sea Limited (SE) and Zevra Therapeutics Inc. (ZVRA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


SEZVRADifference
Sharpe ratioReturn per unit of total volatility

-1.48

Sortino ratioReturn per unit of downside risk

-2.64

Omega ratioGain probability vs. loss probability

0.83

1.16

-0.32

Calmar ratioReturn relative to maximum drawdown

-0.77

0.81

-1.58

Martin ratioReturn relative to average drawdown

-1.27

1.41

-2.68

SE vs. ZVRA - Sharpe Ratio Comparison

The current SE Sharpe Ratio is -0.92, which is lower than the ZVRA Sharpe Ratio of 0.56. The chart below compares the historical Sharpe Ratios of SE and ZVRA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

SE vs. ZVRA - Drawdown Comparison

The maximum SE drawdown since its inception was -90.51%, smaller than the maximum ZVRA drawdown of -99.27%. Use the drawdown chart below to compare losses from any high point for SE and ZVRA.


Loading charts...

Drawdown Indicators


SEZVRADifference

Max Drawdown

Largest peak-to-trough decline

-90.51%

-99.27%

+8.76%

Max Drawdown (1Y)

Largest decline over 1 year

-60.22%

-43.47%

-16.75%

Max Drawdown (3Y)

Largest decline over 3 years

-60.22%

-43.47%

-16.75%

Max Drawdown (5Y)

Largest decline over 5 years

-90.51%

-74.01%

-16.50%

Max Drawdown (10Y)

Largest decline over 10 years

-97.85%

Current Drawdown

Current decline from peak

-77.40%

-96.65%

+19.25%

Average Drawdown

Average peak-to-trough decline

-44.10%

-86.41%

+42.31%

Ulcer Index

Depth and duration of drawdowns from previous peaks

36.57%

24.87%

+11.70%

Volatility

SE vs. ZVRA - Volatility Comparison

The current volatility for Sea Limited (SE) is 14.69%, while Zevra Therapeutics Inc. (ZVRA) has a volatility of 24.56%. This indicates that SE experiences smaller price fluctuations and is considered to be less risky than ZVRA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SEZVRADifference

Volatility (1M)

Calculated over the trailing 1-month period

14.69%

24.56%

-9.87%

Volatility (6M)

Calculated over the trailing 6-month period

38.05%

40.23%

-2.18%

Volatility (1Y)

Calculated over the trailing 1-year period

50.74%

62.90%

-12.16%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

64.13%

60.49%

+3.64%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

62.59%

81.46%

-18.87%

Dividends

SE vs. ZVRA - Dividend Comparison

Neither SE nor ZVRA has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

SE vs. ZVRA - Financials Comparison

This section allows you to compare key financial metrics between Sea Limited and Zevra Therapeutics Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00B20222023202420252026
7.10B
36.22M
(SE) Total Revenue
(ZVRA) Total Revenue
Values in USD except per share items

Frequently Asked Questions


SE and ZVRA have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ZVRA has higher volatility (24.56%) compared to SE (14.69%). In terms of maximum drawdown, SE dropped -90.51% vs ZVRA's -99.27%.

ZVRA currently has the higher Sharpe Ratio (0.56 vs -0.92), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SE and ZVRA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer